Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18287 | 558 | 26.2 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
73 | 3 | MICROBIOLOGY//INFECTIOUS DISEASES//STAPHYLOCOCCUS AUREUS | 82747 |
233 | 2 | ACINETOBACTER BAUMANNII//EXTENDED SPECTRUM BETA LACTAMASE//ESBL | 20247 |
18287 | 1 | FOSFOMYCIN//FOSFOMYCIN TROMETAMOL//FOSFOMYCIN RESISTANCE | 558 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FOSFOMYCIN | authKW | 2090571 | 18% | 38% | 101 |
2 | FOSFOMYCIN TROMETAMOL | authKW | 580999 | 3% | 56% | 19 |
3 | FOSFOMYCIN RESISTANCE | authKW | 443244 | 2% | 90% | 9 |
4 | FOSFOMYCIN TROMETHAMINE | authKW | 273609 | 1% | 100% | 5 |
5 | DISODIUM FOSFOMYCIN | authKW | 109443 | 0% | 100% | 2 |
6 | FOSA3 GENE | authKW | 109443 | 0% | 100% | 2 |
7 | FOSFOMYCIN CALCIUM | authKW | 109443 | 0% | 100% | 2 |
8 | FOSFOMYCIN SUSCEPTIBILITY | authKW | 109443 | 0% | 100% | 2 |
9 | URINARY TRACT INFECTION FEMALE | authKW | 109443 | 0% | 100% | 2 |
10 | AREA PROD PORCINA | address | 72961 | 0% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 6268 | 32% | 0% | 177 |
2 | Microbiology | 5855 | 43% | 0% | 239 |
3 | Pharmacology & Pharmacy | 3053 | 44% | 0% | 243 |
4 | Pathology | 66 | 4% | 0% | 21 |
5 | Medicine, General & Internal | 42 | 6% | 0% | 32 |
6 | Oncology | 38 | 6% | 0% | 36 |
7 | Urology & Nephrology | 34 | 3% | 0% | 17 |
8 | Parasitiology | 18 | 1% | 0% | 8 |
9 | Veterinary Sciences | 13 | 3% | 0% | 16 |
10 | Biochemical Research Methods | 11 | 3% | 0% | 14 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AREA PROD PORCINA | 72961 | 0% | 67% | 2 |
2 | CNRS UNITE AGENTS ANTIBACTERIENS 271 | 72961 | 0% | 67% | 2 |
3 | ADVISORY COMM CONSULTANT MANAGEMENT | 54722 | 0% | 100% | 1 |
4 | ALERTA DOENCAS INFECCIOSAS | 54722 | 0% | 100% | 1 |
5 | CLASS E 2012 7 | 54722 | 0% | 100% | 1 |
6 | CLIN MICROBIOL PREVENT MED CLIN UNIT | 54722 | 0% | 100% | 1 |
7 | EPIDEMIYOL BILIM DALI | 54722 | 0% | 100% | 1 |
8 | FARMACOLUNIDAD FARMACOL CLIN | 54722 | 0% | 100% | 1 |
9 | HOSP BIOTECHNOL | 54722 | 0% | 100% | 1 |
10 | HOSP CLINCARDIOVASC | 54722 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INFECTION | 11409 | 5% | 1% | 28 |
2 | CHEMOTHERAPY | 11396 | 4% | 1% | 23 |
3 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 11003 | 12% | 0% | 69 |
4 | CHEMIOTERAPIA | 9794 | 1% | 2% | 8 |
5 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 8920 | 4% | 1% | 25 |
6 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 5970 | 7% | 0% | 37 |
7 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 5801 | 3% | 1% | 14 |
8 | PATHOLOGIE BIOLOGIE | 5020 | 4% | 0% | 20 |
9 | IMMUNITAT UND INFEKTION | 3550 | 1% | 1% | 6 |
10 | MEDECINE ET MALADIES INFECTIEUSES | 2427 | 2% | 0% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FOSFOMYCIN | 2090571 | 18% | 38% | 101 | Search FOSFOMYCIN | Search FOSFOMYCIN |
2 | FOSFOMYCIN TROMETAMOL | 580999 | 3% | 56% | 19 | Search FOSFOMYCIN+TROMETAMOL | Search FOSFOMYCIN+TROMETAMOL |
3 | FOSFOMYCIN RESISTANCE | 443244 | 2% | 90% | 9 | Search FOSFOMYCIN+RESISTANCE | Search FOSFOMYCIN+RESISTANCE |
4 | FOSFOMYCIN TROMETHAMINE | 273609 | 1% | 100% | 5 | Search FOSFOMYCIN+TROMETHAMINE | Search FOSFOMYCIN+TROMETHAMINE |
5 | DISODIUM FOSFOMYCIN | 109443 | 0% | 100% | 2 | Search DISODIUM+FOSFOMYCIN | Search DISODIUM+FOSFOMYCIN |
6 | FOSA3 GENE | 109443 | 0% | 100% | 2 | Search FOSA3+GENE | Search FOSA3+GENE |
7 | FOSFOMYCIN CALCIUM | 109443 | 0% | 100% | 2 | Search FOSFOMYCIN+CALCIUM | Search FOSFOMYCIN+CALCIUM |
8 | FOSFOMYCIN SUSCEPTIBILITY | 109443 | 0% | 100% | 2 | Search FOSFOMYCIN+SUSCEPTIBILITY | Search FOSFOMYCIN+SUSCEPTIBILITY |
9 | URINARY TRACT INFECTION FEMALE | 109443 | 0% | 100% | 2 | Search URINARY+TRACT+INFECTION+FEMALE | Search URINARY+TRACT+INFECTION+FEMALE |
10 | FOSA3 | 72961 | 0% | 67% | 2 | Search FOSA3 | Search FOSA3 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FALAGAS, ME , VOULOUMANOU, EK , SAMONIS, G , VARDAKAS, KZ , (2016) FOSFOMYCIN.CLINICAL MICROBIOLOGY REVIEWS. VOL. 29. ISSUE 2. P. 321 -347 | 130 | 61% | 6 |
2 | POPOVIC, M , STEINORT, D , PILLAI, S , JOUKHADAR, C , (2010) FOSFOMYCIN: AN OLD, NEW FRIEND?.EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. VOL. 29. ISSUE 2. P. 127 -142 | 68 | 72% | 69 |
3 | SASTRY, S , DOI, Y , (2016) FOSFOMYCIN: RESURGENCE OF AN OLD COMPANION.JOURNAL OF INFECTION AND CHEMOTHERAPY. VOL. 22. ISSUE 5. P. 273 -280 | 62 | 67% | 2 |
4 | ROUSSOS, N , KARAGEORGOPOULOS, DE , SAMONIS, G , FALAGAS, ME , (2009) CLINICAL SIGNIFICANCE OF THE PHARMACOKINETIC AND PHARMACODYNAMIC CHARACTERISTICS OF FOSFOMYCIN FOR THE TREATMENT OF PATIENTS WITH SYSTEMIC INFECTIONS.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 34. ISSUE 6. P. 506-515 | 56 | 69% | 58 |
5 | MICHALOPOULOS, AS , LIVADITIS, IG , GOUGOUTAS, V , (2011) THE REVIVAL OF FOSFOMYCIN.INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. VOL. 15. ISSUE 11. P. E732-E739 | 50 | 63% | 85 |
6 | KEATING, GM , (2013) FOSFOMYCIN TROMETAMOL: A REVIEW OF ITS USE AS A SINGLE-DOSE ORAL TREATMENT FOR PATIENTS WITH ACUTE LOWER URINARY TRACT INFECTIONS AND PREGNANT WOMEN WITH ASYMPTOMATIC BACTERIURIA.DRUGS. VOL. 73. ISSUE 17. P. 1951-1966 | 49 | 56% | 17 |
7 | PARKER, SL , LIPMAN, J , ROBERTS, JA , WALLIS, SC , (2015) A SIMPLE LC-MS/MS METHOD USING HILIC CHROMATOGRAPHY FOR THE DETERMINATION OF FOSFOMYCIN IN PLASMA AND URINE: APPLICATION TO A PILOT PHARMACOKINETIC STUDY IN HUMANS.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 105. ISSUE . P. 39 -45 | 22 | 88% | 7 |
8 | REFFERT, JL , SMITH, WJ , (2014) FOSFOMYCIN FOR THE TREATMENT OF RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS INSIGHTS FROM THE SOCIETY OF INFECTIOUS DISEASES PHARMACISTS.PHARMACOTHERAPY. VOL. 34. ISSUE 8. P. 845 -857 | 34 | 57% | 15 |
9 | SAIPRASAD, PV , KRISHNAPRASAD, K , (2016) EXPLORING THE HIDDEN POTENTIAL OF FOSFOMYCIN FOR THE FIGHT AGAINST SEVERE GRAM-NEGATIVE INFECTIONS.INDIAN JOURNAL OF MEDICAL MICROBIOLOGY. VOL. 34. ISSUE 4. P. 416 -420 | 21 | 84% | 0 |
10 | ZHANEL, GG , WALKTY, AJ , KARLOWSKY, JA , (2016) FOSFOMYCIN: A FIRST-LINE ORAL THERAPY FOR ACUTE UNCOMPLICATED CYSTITIS.CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY. VOL. . ISSUE . P. - | 27 | 63% | 0 |
Classes with closest relation at Level 1 |